van Venrooij, Francine V <br/><br/>
Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.  [electronic resource] 

 -  Diabetes care  Apr 2003 
 - 1216-23 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0149-5992 
<br/><br/><label>Standard No.: </label>10.2337/diacare.26.4.1216  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Atorvastatin<br/>Base Sequence<br/>Carrier Proteins--genetics<br/>Cholesterol--blood<br/>Cholesterol Ester Transfer Proteins<br/>Cholesterol Esters--metabolism<br/>DNA Primers<br/>Diabetes Mellitus, Type 2--blood<br/>Double-Blind Method<br/>Female<br/>Genotype<br/>Glycated Hemoglobin--metabolism<br/>Glycoproteins<br/>Heptanoic Acids--therapeutic use<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Male<br/>Middle Aged<br/>Patient Selection<br/>Placebos<br/>Polymorphism, Genetic<br/>Pyrroles--therapeutic use<br/>Restriction Mapping<br/>Triglycerides--blood